AB 2009 revises plasma center personnel and donor controls

What happened

California enacted AB 2009 on September 27 as Chapter 570. A plasma collection center avoids automatic revocation for a change in its biologics-production lead only if the owner or representative provides the specified signed written notice within five days and submits the replacement application within 30 days. A qualified interim lead may serve no more than 30 calendar days with notice, and the licensee may not operate without medical-director supervision. Failure to submit the replacement application requires revocation, subject to a department-granted additional 30-day good-cause extension. The exception does not generally excuse address or ownership changes.

Paid-donor identification can include qualifying photographs issued by another state, a federal agency, or tribal government as well as DMV identification. Medical directors may authorize and supervise specified screenings and health services by department-approved licensed professionals within their scope, without expanding that scope. The refractometer provisions retain training, physically onsite supervision, quality control, and competency evaluation, while requiring medical-director proficiency and limiting unrelated experience demands for plasma-only services. The law also distinguishes licensed source-plasma donation centers from blood-bank depositories and specifies physician licensure and experience for the identified leadership roles.

Why it matters

A personnel-change exception does not authorize unsupervised operation.

Sources

• AB2009 enacted final textOfficial · California Legislature · 2026-09-27 · Source review 2026-10-11
• California Constitution, Article IV section 8(c), official Assembly 2023–24 editionOfficial · California State Assembly · Source review 2026-10-14